Literature DB >> 18786822

Walking distance on 6-MWT is a prognostic factor in idiopathic pulmonary fibrosis.

Antonella Caminati1, Achille Bianchi, Roberto Cassandro, Maria Rosa Mirenda, Sergio Harari.   

Abstract

BACKGROUND AND AIM OF THE WORK: Idiopathic pulmonary fibrosis (IPF) is a progressive disease with high mortality rates and a median survival of 2-3 years from time of diagnosis. The prognosis for any individual patient, however, is variable. To elucidate the clinical significance of 6-min walking test (6-MWT) in patients with IPF, we sought to assess the relationship between distance walked and desaturation during this test and pulmonary function tests (PFTs). We also evaluate the prognostic value of 6-MWT in comparison with PFTs at baseline and during follow-up.
METHODS: The clinical data of 44 patients with IPF were retrospectively analysed. Twenty-nine patients had an additional evaluation after 12 month of follow-up.
RESULTS: Distance walked in 6 min was independently related to mortality by multivariate analysis. Patients walking less then 212 m had a significantly lower survival than those walking farther, assessed by Kaplan-Meier survival curves (log-rank test, p<0.036). During a mean follow-up period of 19.8 months (range 3.2-46.4), 11 patients died of causes related to disease. Changes in meters walked at 12 months evaluation were also predictive of survival (p=0.05).
CONCLUSIONS: These results confirm that in IPF distance walked in 6 min is independent associated with mortality.

Entities:  

Mesh:

Year:  2008        PMID: 18786822     DOI: 10.1016/j.rmed.2008.07.022

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  31 in total

Review 1.  Respiratory and lower limb muscle function in interstitial lung disease.

Authors:  Marios Panagiotou; Vlasis Polychronopoulos; Charlie Strange
Journal:  Chron Respir Dis       Date:  2016-01-14       Impact factor: 2.444

2.  An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.

Authors:  Ganesh Raghu; Harold R Collard; Jim J Egan; Fernando J Martinez; Juergen Behr; Kevin K Brown; Thomas V Colby; Jean-François Cordier; Kevin R Flaherty; Joseph A Lasky; David A Lynch; Jay H Ryu; Jeffrey J Swigris; Athol U Wells; Julio Ancochea; Demosthenes Bouros; Carlos Carvalho; Ulrich Costabel; Masahito Ebina; David M Hansell; Takeshi Johkoh; Dong Soon Kim; Talmadge E King; Yasuhiro Kondoh; Jeffrey Myers; Nestor L Müller; Andrew G Nicholson; Luca Richeldi; Moisés Selman; Rosalind F Dudden; Barbara S Griss; Shandra L Protzko; Holger J Schünemann
Journal:  Am J Respir Crit Care Med       Date:  2011-03-15       Impact factor: 21.405

3.  Evaluation of the 6-minute walk test in pet dogs.

Authors:  R A Swimmer; E A Rozanski
Journal:  J Vet Intern Med       Date:  2011-02-25       Impact factor: 3.333

4.  Multi-dimensional Assessment of IPF Across a Wide Range of Disease Severity.

Authors:  Hana Serajeddini; Paola Rogliani; Marco Mura
Journal:  Lung       Date:  2018-08-27       Impact factor: 2.584

5.  8-Foot-Up-and-Go Test is Associated with Hospitalizations and Mortality in Idiopathic Pulmonary Fibrosis: A Prospective Pilot Study.

Authors:  Baruch Vainshelboim; Mordechai Reuven Kramer; Jonathan Myers; Avraham Unterman; Shimon Izhakian; Jose Oliveira
Journal:  Lung       Date:  2019-01-02       Impact factor: 2.584

Review 6.  Clinical use of biomarkers of survival in pulmonary fibrosis.

Authors:  Michiel Thomeer; Jan C Grutters; Wim A Wuyts; Stijn Willems; Maurits G Demedts
Journal:  Respir Res       Date:  2010-06-28

7.  Six minute walk distance is a predictor of survival in patients with chronic obstructive pulmonary disease undergoing pulmonary rehabilitation.

Authors:  Esther Dajczman; Rima Wardini; Goulnar Kasymjanova; David Préfontaine; Marc Alexander Baltzan; Norman Wolkove
Journal:  Can Respir J       Date:  2015 Jul-Aug       Impact factor: 2.409

8.  Correlations between gait speed, 6-minute walk distance, physical activity, and self-efficacy in patients with severe chronic lung disease.

Authors:  Zachary S DePew; Craig Karpman; Paul J Novotny; Roberto P Benzo
Journal:  Respir Care       Date:  2013-05-21       Impact factor: 2.258

Review 9.  Pathobiology of frailty in lung disease.

Authors:  Brittany Koons; John R Greenland; Joshua M Diamond; Jonathan P Singer
Journal:  Transl Res       Date:  2020-05-03       Impact factor: 7.012

10.  Desaturation - distance ratio: a new concept for a functional assessment of interstitial lung diseases.

Authors:  Suzana Pinheiro Pimenta; Renata Barbosa da Rocha; Bruno Guedes Baldi; Alexandre de Melo Kawassaki; Ronaldo Adib Kairalla; Carlos Roberto Ribeiro Carvalho
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.